1Papadakis KA. Safety and efficacy of adalimumabin Crohn's disease patients with an attenuated response to infliximab [J]. Gastroenterology, 2011, 100(1): 75-79.
2Cottone M, Papi C, Orlando A. Infliximab, azathioprine or combination therapy in the treatment of active Crohn's disease[J]. Expert Rev Gastroenterol Hepatol, 2010,4(6):709-712.